Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$21.60
-0.07-0.32%
At close: -
$21.60
0.000.00%
After Hours: 4:01 PM EDT
Comments
Loading...
MediWound Analyst Ratings and Price Targets | NASDAQ:MDWD | Benzinga
MediWound Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for MediWound Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Craig-Hallum
Oppenheimer
Cowen & Co.
Maxim Group
1calculated from analyst ratings
Analyst Ratings for MediWound
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/22/2025 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $25 → $31 | Maintains | Buy | Get Alert |
| 03/20/2025 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | Buy Now | — | Craig-Hallum | Chase Knickerbocker59% | → $39 | Initiates | → Buy | Get Alert |
| 01/10/2025 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/27/2024 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $28 → $25 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 07/16/2024 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/22/2024 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2024 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $26 → $28 | Maintains | Buy | Get Alert |
| 11/22/2023 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | → $26 | Reiterates | Buy → Buy | Get Alert |
| 09/21/2023 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $23 → $26 | Maintains | Buy | Get Alert |
| 08/17/2023 | Buy Now | — | Oppenheimer | Francois Brisebois40% | $63 → $36 | Maintains | Outperform | Get Alert |
| 08/17/2023 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 05/31/2023 | Buy Now | — | Oppenheimer | Francois Brisebois40% | → $63 | Reiterates | Outperform → Outperform | Get Alert |
| 05/31/2023 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 03/17/2023 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | → $23 | Reiterates | → Buy | Get Alert |
| 01/04/2023 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $5.5 → $23 | Maintains | Buy | Get Alert |
| 12/30/2022 | Buy Now | — | Cowen & Co. | Joshua Jennings56% | $6 → $25 | Maintains | Outperform | Get Alert |
| 12/22/2022 | Buy Now | — | Maxim Group | Michael Okunewitch30% | → $25 | Initiates | → Buy | Get Alert |
| 12/21/2022 | Buy Now | — | Oppenheimer | Francois Brisebois40% | $9 → $63 | Maintains | Outperform | Get Alert |
| 11/16/2022 | Buy Now | — | HC Wainwright & Co. | Swayampakula Ramakanth53% | $6 → $5.5 | Maintains | Buy | Get Alert |
| 07/18/2022 | Buy Now | — | Oppenheimer | Francois Brisebois40% | → $7 | Assumes | → Outperform | Get Alert |
FAQ
What is the target price for MediWound (MDWD) stock?
The latest price target for MediWound (NASDAQ:MDWD) was reported by HC Wainwright & Co. on May 22, 2025. The analyst firm set a price target for $31.00 expecting MDWD to rise to within 12 months (a possible 43.52% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MediWound (MDWD)?
The latest analyst rating for MediWound (NASDAQ:MDWD) was provided by HC Wainwright & Co., and MediWound maintained their buy rating.
When was the last upgrade for MediWound (MDWD)?
There is no last upgrade for MediWound
When was the last downgrade for MediWound (MDWD)?
There is no last downgrade for MediWound.
When is the next analyst rating going to be posted or updated for MediWound (MDWD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MediWound, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MediWound was filed on May 22, 2025 so you should expect the next rating to be made available sometime around May 22, 2026.
Is the Analyst Rating MediWound (MDWD) correct?
While ratings are subjective and will change, the latest MediWound (MDWD) rating was a maintained with a price target of $25.00 to $31.00. The current price MediWound (MDWD) is trading at is $21.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
